Broadly neutralizing antibody treatment may target viral reservoir in monkeys

After receiving a course of antiretroviral therapy for their HIV-like infection, approximately half of a group of monkeys infused with a broadly neutralizing antibody to HIV combined with an immune stimulatory compound suppressed the virus for six months without additional treatment, according to a new study. The therapy may have targeted the viral reservoir -- populations of long-lived, latently infected cells that harbor the virus and that lead to resurgent viral replication when suppressive therapy is discontinued. https://www.sciencedaily.com/releases/2018/03/180304170005.htm